In a prospective study of 26 premature infants, 5 ,l microdrops were compared with standard 26 ul eye drops of cyclopentolate 0-5% and phenylephrine 2 5%. There was no statistical difference in pupil dilatation. The 5 gl microdrops have potentially fewer adverse effects in premature infants. (BrJf Ophthalmol 1993; 77: 364-365) Systemic toxicity from 
Systemic toxicity from cyclopentolate and phenylephrine eye drops is well documented in adults and children.'2 Screening all at risk infants for retinopathy of prematurity is now recommended. 3 Cyclopentolate drops 0 5% and phenylephrine drops 2 5% are suggested for pupil dilatation in neonates but even these lower strengths have been shown to have systemic effects."5 This paper presents the results of a prospective study on the effect on pupil dilatation when mydriatic drop size is reduced to standard drops may be lost in the first 15-30 seconds via the nasolacrimal duct, conjunctival blood vessels, or spillage onto the skin. Systemic absorption is directly into the circulation from the conjunctival and nasal mucosa without first pass metabolism in the liver. Therefore systemically absorbed eye drops are more like intravenous agents than oral ones. 7 There was no statistically significant difference in pupil dilatation in this study between the smaller 5 ul drop size and the conventional 26 ul drop size. Equal pupil dilatation has been demonstrated with 8 ,ul and 30 ul drops of phenylephrine in neonates but the pupil size was only 4-86 mm and 4-57 mm respectively.8 The pupil diameter was larger in this study which is compatible with the results of Carpel and Kalina who showed there was an additional effect in premature infants when cyclopentolate was added.9 In adults reduction in drop size of phenylephrine 10% and tropicamide 1% produces adequate mydriasis. 6 Brown et al have shown that drop size can be reduced by designing a bottle with a narrower outlet.'0 The systemic absorption is less with a smaller than a larger drop volume.8 Infants in particular may be more likely to absorb eye drops systemically as the tear volume is small and the drops are instilled supine so that spillage onto the skin may be less. " The risk oftoxicity may also be increased because of low body mass and the immaturity of the cardiovascular and nervous systems.4 Cyclopentolate in adults and children may cause psychosis, behavioural disturbance, ataxia, agitation, fits, and gastrointestinal upset.'2 Preterm twins developed gastrointestinal side effects from cyclopentolate 1%, and abdominal distension and increased gastric aspirate was reported in 50 preterm infants examined for retinopathy of prematurity.512 There are many reports of cardiovascular adverse effects from phenylephrine.' 2 Raised blood pressure has been observed in preterm infants after dilatation with 2 5% phenylephrine and this potentially increases the risk of intraventricular haemorrhage. 4 The risk of adverse systemic effects from eye drops is well recognised and as more and more premature babies are being examined it would be better medical practice not to use over five times more medication than is required. Other 'quacks' were placed in the pillory so that the public -even less polite than they are now -could throw mud and rotten eggs at them and generally abuse them.
Today, of course, all three would merely be struck off for malpractice, though Taylor, at least, would easily regain his fame and fortune in the sphere of public relations. Or possibly at Westminster.
